207 related articles for article (PubMed ID: 34911575)
1. STAT3 inhibitor mitigates cerebral amyloid angiopathy and parenchymal amyloid plaques while improving cognitive functions and brain networks.
Mehla J; Singh I; Diwan D; Nelson JW; Lawrence M; Lee E; Bauer AQ; Holtzman DM; Zipfel GJ
Acta Neuropathol Commun; 2021 Dec; 9(1):193. PubMed ID: 34911575
[TBL] [Abstract][Full Text] [Related]
2. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
[TBL] [Abstract][Full Text] [Related]
3. Early-onset formation of parenchymal plaque amyloid abrogates cerebral microvascular amyloid accumulation in transgenic mice.
Xu F; Kotarba AE; Ou-Yang MH; Fu Z; Davis J; Smith SO; Van Nostrand WE
J Biol Chem; 2014 Jun; 289(25):17895-908. PubMed ID: 24828504
[TBL] [Abstract][Full Text] [Related]
4. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
[TBL] [Abstract][Full Text] [Related]
5. Border-associated macrophages promote cerebral amyloid angiopathy and cognitive impairment through vascular oxidative stress.
Uekawa K; Hattori Y; Ahn SJ; Seo J; Casey N; Anfray A; Zhou P; Luo W; Anrather J; Park L; Iadecola C
Mol Neurodegener; 2023 Oct; 18(1):73. PubMed ID: 37789345
[TBL] [Abstract][Full Text] [Related]
6. APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function.
Xiong M; Jiang H; Serrano JR; Gonzales ER; Wang C; Gratuze M; Hoyle R; Bien-Ly N; Silverman AP; Sullivan PM; Watts RJ; Ulrich JD; Zipfel GJ; Holtzman DM
Sci Transl Med; 2021 Feb; 13(581):. PubMed ID: 33597265
[TBL] [Abstract][Full Text] [Related]
7. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
8. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer's disease.
Bourassa P; Tremblay C; Schneider JA; Bennett DA; Calon F
Acta Neuropathol; 2019 May; 137(5):801-823. PubMed ID: 30729296
[TBL] [Abstract][Full Text] [Related]
9. Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline.
Rabin JS; Nichols E; La Joie R; Casaletto KB; Palta P; Dams-O'Connor K; Kumar RG; George KM; Satizabal CL; Schneider JA; Pa J; Brickman AM
Brain; 2022 Aug; 145(8):2823-2833. PubMed ID: 35759327
[TBL] [Abstract][Full Text] [Related]
10. Fruquintinib/HMPL-013 ameliorates cognitive impairments and pathology in a mouse model of cerebral amyloid angiopathy (CAA).
Zhou G; Xiang T; Xu Y; He B; Wu L; Zhu G; Xie J; Yao L; Xiao Z
Eur J Pharmacol; 2023 Jan; 939():175446. PubMed ID: 36470443
[TBL] [Abstract][Full Text] [Related]
11. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor prevents APOE4 and amyloid-beta-induced cognitive and cerebrovascular deficits in female mice.
Thomas R; Zuchowska P; Morris AW; Marottoli FM; Sunny S; Deaton R; Gann PH; Tai LM
Acta Neuropathol Commun; 2016 Oct; 4(1):111. PubMed ID: 27788676
[TBL] [Abstract][Full Text] [Related]
13. Caffeoylquinic Acid Mitigates Neuronal Loss and Cognitive Decline in 5XFAD Mice Without Reducing the Amyloid-β Plaque Burden.
Suganuma T; Hatori S; Chen CK; Hori S; Kanuka M; Liu CY; Tatsuzawa C; Yanagisawa M; Hayashi Y
J Alzheimers Dis; 2024; 99(4):1285-1301. PubMed ID: 38788074
[TBL] [Abstract][Full Text] [Related]
14. Resorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy.
Han BH; Zhou ML; Vellimana AK; Milner E; Kim DH; Greenberg JK; Chu W; Mach RH; Zipfel GJ
Mol Neurodegener; 2011 Dec; 6():86. PubMed ID: 22192811
[TBL] [Abstract][Full Text] [Related]
15. LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-β.
Kanekiyo T; Liu CC; Shinohara M; Li J; Bu G
J Neurosci; 2012 Nov; 32(46):16458-65. PubMed ID: 23152628
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Pathological Benefit of Twendee X in Alzheimer's Disease Transgenic Mice with Chronic Cerebral Hypoperfusion.
Liu X; Yamashita T; Shang J; Shi X; Morihara R; Huang Y; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1993-2002. PubMed ID: 31029568
[TBL] [Abstract][Full Text] [Related]
17. Cerebral microvascular rather than parenchymal amyloid-β protein pathology promotes early cognitive impairment in transgenic mice.
Xu W; Xu F; Anderson ME; Kotarba AE; Davis J; Robinson JK; Van Nostrand WE
J Alzheimers Dis; 2014; 38(3):621-32. PubMed ID: 24037035
[TBL] [Abstract][Full Text] [Related]
18. Cognitive and cerebrovascular improvements following kinin B1 receptor blockade in Alzheimer's disease mice.
Lacoste B; Tong XK; Lahjouji K; Couture R; Hamel E
J Neuroinflammation; 2013 May; 10():57. PubMed ID: 23642031
[TBL] [Abstract][Full Text] [Related]
19. Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice.
Han BH; Zhou ML; Johnson AW; Singh I; Liao F; Vellimana AK; Nelson JW; Milner E; Cirrito JR; Basak J; Yoo M; Dietrich HH; Holtzman DM; Zipfel GJ
Proc Natl Acad Sci U S A; 2015 Feb; 112(8):E881-90. PubMed ID: 25675483
[TBL] [Abstract][Full Text] [Related]
20. Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease.
Merlini M; Shi Y; Keller S; Savarese G; Akhmedov A; Derungs R; Spescha RD; Kulic L; Nitsch RM; Lüscher TF; Camici GG
Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H232-H238. PubMed ID: 27836896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
